Milestone Pharmaceuticals Inc. announced the appointment of Michael Tomsicek to its board of directors. In addition to serving on the board of directors at Milestone, Mr. Tomsicek will also serve as chairman of the board's audit committee. Mr. Tomsicek brings over 20 years of corporate and financial leadership experience to Milestone. Prior to joining CRISPR, Mr. Tomsicek served as the Chief Financial Officer of Abiomed, a leading medical device company developing and commercializing products to aid in circulatory support. Mr. Tomsicek has also served as Chief Financial Officer at Cubist Pharmaceuticals, where he held various roles in financial operations, investor relations, and corporate strategy.